BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 9275416)

  • 1. [Persistent and recurrent gynecologic malignant tumor treated within one year: analysis of 1,753 cases from 61 hospitals in China].
    Cao Z; Yu S
    Zhonghua Fu Chan Ke Za Zhi; 1996 Jul; 31(7):417-21. PubMed ID: 9275416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gynecologic cancers: factors affecting survival after pulmonary metastasectomy.
    Clavero JM; Deschamps C; Cassivi SD; Allen MS; Nichols FC; Barrette BA; Larson DR; Pairolero PC
    Ann Thorac Surg; 2006 Jun; 81(6):2004-7. PubMed ID: 16731120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical analysis of 42 cases of primary malignant melanoma in female genital tract].
    An JS; Wu LY; Li N; Li B; Yu GZ; Liu LY
    Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):320-4. PubMed ID: 17673044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Constitutive characteristics and change trend of gynecological malignant tumors in 8009 hospitalized patients in Guangxi Zhuang Autonomous Region].
    Huang W; Li L; Yu DQ; Huang YL; Liu Y; Chen XQ; Tang BJ; Xu H; Ma G; Dong LH; Li L; Qiu Y; Bai H; Nong WZ; Li L; Zeng DY; Jiang FY; Lan Y; Ye Y; Tang XZ; Wang DX; Li HZ; Pan YB; Mo AX; Wu XY; Lei ZY; Zhou GP; Liu C; Su QH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):22-5. PubMed ID: 17331416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Primary malignant lymphoma of the female genital tract clinical analysis of 15 cases].
    Bai P; Sun J
    Zhonghua Fu Chan Ke Za Zhi; 1995 Oct; 30(10):614-7. PubMed ID: 8745510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of prognostic factor and treatment mode for undifferentiated cervical carcinoma].
    Zhang Y; Li M; Wang H
    Zhonghua Fu Chan Ke Za Zhi; 2000 Jan; 35(1):45-7. PubMed ID: 11831951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Human and medical aspects of treatment of recurrent gynecologic cancer].
    Revaz C
    Rev Med Suisse Romande; 1969 Jun; 89(6):679-95. PubMed ID: 5398848
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of malignant tumors in gynecology].
    Ledermair O; Michlmayr G; Hammer J
    Wien Med Wochenschr; 1986 Jun; 136(11-12):307-11. PubMed ID: 3751078
    [No Abstract]   [Full Text] [Related]  

  • 10. Pre-pregnancy counselling of premalignant and malignant disease.
    Harris JW
    Clin Obstet Gynaecol; 1982 Apr; 9(1):171-98. PubMed ID: 7049496
    [No Abstract]   [Full Text] [Related]  

  • 11. Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers.
    Fleisch MC; Pantke P; Beckmann MW; Schnuerch HG; Ackermann R; Grimm MO; Bender HG; Dall P
    J Surg Oncol; 2007 May; 95(6):476-84. PubMed ID: 17192947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locoregional recurrence of breast cancer: a retrospective comparison of treatment methods.
    Skowronek J; Piotrowski T
    Neoplasma; 2002; 49(6):426-31. PubMed ID: 12584593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent squamous cell carcinoma of cervix after definitive radiotherapy.
    Hong JH; Tsai CS; Lai CH; Chang TC; Wang CC; Chou HH; Lee SP; Hsueh S
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):249-57. PubMed ID: 15337563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of recurrent and persistent disease of malignant ovarian germ cell tumor: a retrospective analysis at King Chulalongkorn Memorial Hospital.
    Lertkhachonsuk R; Manchana T; Termrungruanglert W; Vasuratna A; Sittisomwong T; Worasethsin P; Sirisabya N; Khemapech N; Tresukosol D
    J Med Assoc Thai; 2006 Feb; 89(2):138-44. PubMed ID: 16578998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Early recurrent factors of ovarian cancer after treatment].
    Zhang JQ; Li L; Chen XQ
    Ai Zheng; 2003 Nov; 22(11):1201-3. PubMed ID: 14613653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of squamous cell carcinoma antigen in patients with recurrent squamous cell carcinoma of the uterine cervix].
    Ma SK; Wu LY; Sun YC; Li B; Zhang HT
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):13-7. PubMed ID: 18366925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical analysis of ovarian and cervical malignant lymphoma].
    Wang WF; Sun R; Zhao XY
    Zhonghua Fu Chan Ke Za Zhi; 1994 Jan; 29(1):23-6, 60. PubMed ID: 8033620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indications for primary and secondary exenterations in patients with cervical cancer.
    Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
    Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome and prognostic factors in ovarian germ cell malignancies.
    Lai CH; Chang TC; Hsueh S; Wu TI; Chao A; Chou HH; Wang PN
    Gynecol Oncol; 2005 Mar; 96(3):784-91. PubMed ID: 15721426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy for centrally recurrent cervical cancer of the vaginal stump following hysterectomy.
    Ito H; Shigematsu N; Kawada T; Kubo A; Isobe K; Hara R; Yasuda S; Aruga T; Ogata H
    Gynecol Oncol; 1997 Nov; 67(2):154-61. PubMed ID: 9367699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.